Literature DB >> 1486891

Impaired detection of faecal verocytotoxin in the presence of Clostridium difficile cytotoxin in patients with haemolytic uraemic syndrome.

I Luzzi1, F Minelli, A Gianviti, A Caprioli.   

Abstract

Three cases of haemolytic uraemic syndrome associated with infection with verocytotoxin producing Escherichia coli are described. The concomitant presence of Clostridium difficile cytotoxin in the patients' stool impaired the detection of free faecal verocytotoxin. Stool specimens containing Clostridium difficile cytotoxin should thus be considered negative for verocytotoxin only after neutralisation of the Clostridium difficile cytotoxin with antitoxin.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1486891     DOI： 10.1007/bf01962378

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  11 in total

1.  Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology.

Authors:  P I Tarr; M A Neill; C R Clausen; S L Watkins; D L Christie; R O Hickman
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

2.  The carrier state: Clostridium difficile.

Authors:  R H George
Journal:  J Antimicrob Chemother       Date:  1986-07       Impact factor: 5.790

Review 3.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

Review 4.  Clostridium difficile: clinical considerations.

Authors:  J G Bartlett
Journal:  Rev Infect Dis       Date:  1990 Jan-Feb

5.  Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects.

Authors:  H Kleanthous; H R Smith; S M Scotland; R J Gross; B Rowe; C M Taylor; D V Milford
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

6.  Hemolytic-uremic syndrome and Vero cytotoxin-producing Escherichia coli infection in Italy. The HUS Italian Study Group.

Authors:  A Caprioli; I Luzzi; F Rosmini; P Pasquini; R Cirrincione; A Gianviti; M C Matteucci; G Rizzoni
Journal:  J Infect Dis       Date:  1992-07       Impact factor: 5.226

7.  Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins.

Authors:  E L Lopez; M Diaz; S Grinstein; S Devoto; F Mendilaharzu; B E Murray; S Ashkenazi; E Rubeglio; M Woloj; M Vasquez
Journal:  J Infect Dis       Date:  1989-09       Impact factor: 5.226

8.  High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome.

Authors:  M Bitzan; E Moebius; K Ludwig; D E Müller-Wiefel; J Heesemann; H Karch
Journal:  J Pediatr       Date:  1991-09       Impact factor: 4.406

Review 9.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

10.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226
View more
  1 in total

1.  Production of enterotoxin, verotoxin, hemolysin and cytotoxic necrotizing factor by Escherichia coli of intestinal and extraintestinal origin.

Authors:  A Hostacká
Journal:  Folia Microbiol (Praha)       Date:  1994       Impact factor: 2.099
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.